Genentech/Biogen 2nd Generation Anti-CD20 I think you'll find the story here: <a href="http://www.gene.com/gene/pipeline/status/immunology/ocrelizumab/" rel="nofollow" target="_blank">http://www.gene.com/gene/pipeline/status/immunology/ocrelizumab/</a> And the arbitration panel decision here: <a href="http://www.gene.com/gene/news/gne_biib_arb.html" rel="nofollow" target="_blank">http://www.gene.com/gene/news/gne_biib_arb.html</a>